UTAH MEDICAL PRODUCTS, INC.
|
||
(Exact name of registrant as specified in its charter)
|
||
Utah
|
000-12575
|
87-0342734
|
(State or other jurisdiction of
|
(Commission File Number)
|
(IRS Employer
|
incorporation or organization)
|
Identification No.)
|
7043 South 300 West
|
|||
Midvale, Utah
|
84047
|
||
(Address of principal executive offices)
|
(Zip code)
|
||
Registrant’s telephone number, including area code:
|
Phone: (801) 566-1200
|
||
n/a
|
|||
(Former name or former address, if changed since last report)
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).
|
|
Emerging growth company [ ]
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. [ ]
|
Exhibit
Number
|
Title of Document
|
Location
|
||
Other Events
|
||||
Item 99.1
|
UTMD Postpones its 2020 Annual Stockholders’ Meeting for Three Months
|
Attached
|
UTAH MEDICAL PRODUCTS, INC.
|
||
Dated: March 23, 2020
|
By:
|
/s/ Kevin L. Cornwell |
Kevin L. Cornwell, Chairman & CEO
|